Supercharge Your Innovation With Domain-Expert AI Agents!

Application of bifidobacterium breve M-16V in medicine preparation

A technology of Bifidobacterium breve and medicine, applied in the field of medicine, can solve the problems of inability to defend, excessive attack, etc., and achieve the effect of improving the immunity of the body

Pending Publication Date: 2022-07-22
RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Immune dysfunction is that under the action of certain inducements (fatigue, alcoholism, allergens, etc.), the immune system fails to truly and effectively play a self-defense function, or is too strong to attack, or too weak to defend

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of bifidobacterium breve M-16V in medicine preparation
  • Application of bifidobacterium breve M-16V in medicine preparation
  • Application of bifidobacterium breve M-16V in medicine preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] An in vivo mouse model of immune disorder was established with polystyrene, and the therapeutic effect of Bifidobacterium breve M-16V on immune disorders was studied through the intervention of Bifidobacterium breve M-16V.

[0032] Two-month-old ICR mice were selected, and the model group was given 5 μm polystyrene 1000 μg / L by gavage for 4 weeks, six days a week. Treatment group: 2 × 10 8 CFU / g / d Bifidobacterium breve M-16V, the gavage time was the same as the model group; control group: PBS was gavage, the gavage time was the same as above.

[0033] One month after oral gavage, mice were euthanized and tissues were collected. For experimental purposes, the spleen was mechanically isolated into a single-cell suspension for further measurements. Feces and intestines were stored at -80°C for 16S rDNA gene sequencing, untargeted metabolomic detection and RT-PCR analysis, respectively.

[0034] Bifidobacterium breve M-16V can change the composition of intestinal flora a...

Embodiment 2

[0036] Changes in splenic lymphocyte subsets were determined by flow cytometry. Wash T cells with flow cytometry staining buffer, block T cells with Fc blocking solution, and stain at 4°C for 30 min. Resuspend after washing. 10 in 100 μL PBS 6 cells were added to a 5 mL fluorescence-activated cell sorting tube. T cell depletion / replenishment kinetics were analyzed by flow cytometry.

[0037] like figure 2 As shown, the immunotoxicity of PS may be directly attributed to the hyperfunction of antigen-specific Th2 cells and the marked decrease of Th1 cells, which leads to the occurrence of type 2 immunity. The role of Bifidobacterium breve M-16V in the differentiation of spleen lymphocytes was shown to inhibit the levels of Th2 and Th17 lymphocyte subsets. Dietary intervention with Bifidobacterium breve M-16V suppressed allergic symptoms and reduced Th2 activation in mice.

Embodiment 3

[0039] Total RNA was isolated from the gut using Trizol reagent. RNA was then used to synthesize cDNA using a reverse transcriptase kit. RT-PCR was performed using SYBR Green system.

[0040] Primer sequence:

[0041] MyD88, F: GTGAACTGGAAGATCTTCGAGA, as shown in SEQ ID NO.1;

[0042] R: ACTTGGTCAGTACTTTAGGTGG; as shown in SEQ ID NO.2.

[0043] MHC-II, F: GTGAACTGGAAGATCTTCGAGA, as shown in SEQ ID NO.3;

[0044] R: ACTTGGTCAGTACTTTAGGTGG; as shown in SEQ ID NO.4.

[0045] TRIF, F: ACGATCCTGCTCCTGACTGCTAG, as shown in SEQ ID NO.5;

[0046] R:TCCTGCCTCCCAGACTGTGTAAG; as shown in SEQ ID NO.6.

[0047] GAPDH transcript levels were identified as a housekeeping gene. RT-PCR was performed as follows: denaturation for 10 min at 95°C, followed by 40 cycles of 10s at 95°C and 30s at 60°C. use 2 -ΔΔCt The relative quantification of gene expression was calculated by the method.

[0048] like image 3The results of RT-PCR detection of the expression of key genes in the small int...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of bifidobacterium breve M-16V in preparation of drugs, and the bifidobacterium breve M-16V can relieve immune function disorder caused by micro-plastic nano polystyrene, maintain normal immune function, enhance body immunity and further prevent occurrence of diseases. Therefore, the compound has a certain effect in preparation of drugs for preventing or treating immune dysfunction.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to the application of Bifidobacterium breve M-16V in preparing medicine. Background technique [0002] The immune system is the last physiological system to appear in the history of biological evolution, and it is also one of the most mysterious functional systems. When a certain factor makes a certain component of the immune system change in one way or another, it may affect the strength or efficiency of immune function, but the basic function of the immune system must be maintained, otherwise the body will have a series of immune function-related problems. . Immune dysfunction is that under the action of certain incentives (fatigue, alcoholism, allergens, etc.), the immune system fails to play a real and effective self-defense function, or is too strong to attack, or too weak to defend. [0003] Nano-polystyrene, a common microplastic widely used in packaging and construction, may enter ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/745A61P37/04A61P29/00A61P1/00A23L33/135
CPCA61K35/745A61P37/04A61P29/00A61P1/00A23L33/135A23V2002/00A23V2400/519A23V2200/324A23V2200/30A23V2200/3204
Inventor 李娜许春娣李金华王珺王歆琼高深甚陈美如
Owner RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More